• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, July 14, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

The Lancet: A warning and an opportunity: The WHO Independent

Bioengineer by Bioengineer
June 1, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

It poses a stark warning that the Sustainable Development Goal for NCDs – to reduce premature deaths from NCDs by a third by 2030 and promote mental health – will not be met at the current rate of progress.

The WHO Independent High-Level Commission on NCDs was established by WHO Director-General, Dr Tedros Adhanom Ghebreyesus, in October 2017. It gathers the best available evidence, including major input from The Lancet Taskforce on NCDs and economics, which published earlier this year [1] and is a partner of the WHO's Independent High-Level Commission on NCDs.

The report of the WHO Commission was timed to coincide with the inter-governmental negotiations underway in New York in the run up to the third UN High-Level Meeting on NCDs, scheduled for September 2018 [2]. In the lead up to this, The Lancet family of journals is also publishing several major initiatives to put the best evidence at the heart of policies to reduce the global burden of NCDs [3].

The WHO Independent High-Level Commission on NCDs prioritises both the main NCDs (cardiovascular diseases, cancers, respiratory diseases, and diabetes) and their risk factors (tobacco use, harmful alcohol consumption, unhealthy diet and physical inactivity), as well as mental health, and air pollution as a risk factor for NCDs.

The authors acknowledge that there are obstacles to implementing proven interventions for NCDs in many countries. The Commission was also unable to reach a consensus on taxation on sugar-sweetened beverages and the accountability of the private sector.

The report proposes six recommendations, including:

  • Recommendation 1: Increased political leadership and responsibility – Action on NCDs requires an upgrade in political leadership, and Heads of State and Governments must take the lead.
  • Recommendation 2: Prioritisation and scaling up – Governments should identify and implement a specific set of priorities within the overall NCD and mental health agenda.
  • Recommendation 3: Embed and expand NCDs within health systems and universal healthcare (UHC) – Synergies should be identified in existing chronic care platforms.
  • Recommendation 4: Collaborate and regulate – Governments should increase effective regulation and appropriate engagement with the private sector and civil society using a whole of society approach.
  • Recommendation 5: Improve financing – Implementing new means to invest in programmes to reverse the tide of NCDs – a new multi-donor fund, increased lending by international financial institutions for NCDs, an investors forum, and higher contributions to multilateral institutions, such as WHO, to ensure programme delivery.
  • Recommendation 6: Improve accountability – Accountability must be strengthened to ensure that the promises and commitments of Governments and the private sector are delivered. This includes through initiatives such as The Lancet Countdown 2030 for NCDs.

Writing in the Commission, the authors say: "The challenge is not only to gain political support, but also to guarantee implementation, whether through legislation, norms and standards setting, or investment. We need to keep arguing for NCDs and mental health to have greater priority, but countries must also take responsibility for delivery on agreed outputs and outcomes, as stated in endorsed documents. There is no excuse for inaction, as we have evidence-based solutions."

###

NOTES TO EDITORS

[1] For more information about The Lancet Taskforce on NCDs and economics, please see: https://www.thelancet.com/series/Taskforce-NCDs-and-economics

[2] http://www.who.int/ncds/governance/third-un-meeting/en/

[3] For more information about The Lancet's work on NCDs, please see: http://info.thelancet.com/infocus-ncds

IF YOU WISH TO PROVIDE A LINK FOR YOUR READERS, PLEASE USE THE FOLLOWING, WHICH WILL GO LIVE AT THE TIME THE EMBARGO LIFTS: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31258-3/fulltext

Media Contact

Dr Sania Nishtar
[email protected]
@TheLancet

http://www.thelancet.com/home

Share12Tweet8Share2ShareShareShare2

Related Posts

Paintable electrodes advance colorful, flexible wearable sensor technology

July 14, 2026

Half of New York Pedestrian Deaths Linked to Substance-Impaired Awareness

July 14, 2026

Tumor Profiling Reveals Chemotherapy Effects and Personalized Treatments for Ovarian Cancer

July 14, 2026

Advances and Challenges in Placenta Models for HIV-1, ART, and Nicotine Research

July 14, 2026
Please login to join discussion

POPULAR NEWS

  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • Experimental Therapy Simultaneously Destroys Prostate Tumor Cells and Reactivates Antitumor Immunity

    46 shares
    Share 18 Tweet 12
  • 高齢者の骨粗鬆症治療の持続性比較

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Carbon Capture Can Reduce Emissions from AI Data Center Growth

KRAS Drugs Offer New Hope for Rare Appendix Cancer Treatment

Atomic Structure in Metals Forms Corrosion Pathways in Nuclear Reactors

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.